Gå offline med appen Player FM !
Podcasts der er værd at lytte til
SPONSORERET
![You Can’t Make This Up podcast artwork](https://cdn.player.fm/images/21055062/series/xUxSMTjIutrzxfGp/32.jpg 32w, https://cdn.player.fm/images/21055062/series/xUxSMTjIutrzxfGp/64.jpg 64w, https://cdn.player.fm/images/21055062/series/xUxSMTjIutrzxfGp/128.jpg 128w, https://cdn.player.fm/images/21055062/series/xUxSMTjIutrzxfGp/256.jpg 256w, https://cdn.player.fm/images/21055062/series/xUxSMTjIutrzxfGp/512.jpg 512w)
![You Can’t Make This Up podcast artwork](/static/images/64pixel.png)
Treatment of Advanced Urothelial Carcinoma – A Discussion of EV-301
Manage episode 331831142 series 2812899
Welcome to our podcast episode on the treatment of urothelial carcinoma. In this episode, hosted by Anna Christofides, we discuss updated results of the Phase 3 EV-301 trial, presented at ASCO 2022, that examined the efficacy and safety of Enfortumab Vedotin, or EV, versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial carcinoma.
Our Guest:
Our guest for this episode is Dr Nimira Alimohamed, Medical Oncologist and Clinical Associate Professor of Medicine at the University of Calgary and Medical Oncologist at the Tom Baker Cancer Centre in Calgary, Alberta.
This podcast episode was sponsored by Seagen Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com
68 episoder
Manage episode 331831142 series 2812899
Welcome to our podcast episode on the treatment of urothelial carcinoma. In this episode, hosted by Anna Christofides, we discuss updated results of the Phase 3 EV-301 trial, presented at ASCO 2022, that examined the efficacy and safety of Enfortumab Vedotin, or EV, versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial carcinoma.
Our Guest:
Our guest for this episode is Dr Nimira Alimohamed, Medical Oncologist and Clinical Associate Professor of Medicine at the University of Calgary and Medical Oncologist at the Tom Baker Cancer Centre in Calgary, Alberta.
This podcast episode was sponsored by Seagen Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com
68 episoder
すべてのエピソード
×![Artwork](/static/images/128pixel.png)
1 Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape 17:37
![Artwork](/static/images/128pixel.png)
1 Highlights from EHA 2024 - Updates on the Treatment of CLL 42:13
![Artwork](/static/images/128pixel.png)
1 LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL 16:33
![Artwork](/static/images/128pixel.png)
1 Cutting Edge Advances in the Treatment of Lung Cancer 15:13
![Artwork](/static/images/128pixel.png)
1 Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers 41:28
![Artwork](/static/images/128pixel.png)
1 Immunotherapy for Kidney Transplant Patients with Skin Cancer 21:32
![Artwork](/static/images/128pixel.png)
1 Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective 24:11
![Artwork](/static/images/128pixel.png)
1 LIVE FROM ASH 2023: Isa-CYBORD induction chemotherapy in newly diagnosed, transplant eligible MM 16:58
![Artwork](/static/images/128pixel.png)
1 Live from ASH 2023: Dr Brown Discusses Updated Results of the ALPINE Trial in CLL 13:48
![Artwork](/static/images/128pixel.png)
1 First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on 1L LA/mUC 32:28
![Artwork](/static/images/128pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion 26:41
![Artwork](/static/images/128pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion 8:07
![Artwork](/static/images/128pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 2 - First-Line Treatment 14:52
![Artwork](/static/images/128pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 1 - Unmet Needs 10:38
Velkommen til Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.